KR840007579A - 신규 니트로 알리파틱화합물의 제조방법 - Google Patents

신규 니트로 알리파틱화합물의 제조방법 Download PDF

Info

Publication number
KR840007579A
KR840007579A KR1019830006225A KR830006225A KR840007579A KR 840007579 A KR840007579 A KR 840007579A KR 1019830006225 A KR1019830006225 A KR 1019830006225A KR 830006225 A KR830006225 A KR 830006225A KR 840007579 A KR840007579 A KR 840007579A
Authority
KR
South Korea
Prior art keywords
formula
compound
lower alkyl
carboxy
hydrogen
Prior art date
Application number
KR1019830006225A
Other languages
English (en)
Other versions
KR910006761B1 (ko
Inventor
마사노리(외 6) 오까모도
Original Assignee
후지사와 도모기찌로
후지사와 야꾸힝 고교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지사와 도모기찌로, 후지사와 야꾸힝 고교 가부시끼가이샤 filed Critical 후지사와 도모기찌로
Publication of KR840007579A publication Critical patent/KR840007579A/ko
Application granted granted Critical
Publication of KR910006761B1 publication Critical patent/KR910006761B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/40—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/51—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

내용 없음.

Description

신규 니트로 알리파틱화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 구조식(II)의 화합물 또는 그 염을 2,3산화질소와 반응시켜서 구조식(Ia)의 화합물 또는 그염을 제조하거나, 구조식(Ib)의 화합물 또는 그염을 알킬화제와 반응시켜서 구조식(Ic)의 화합물 또는 그염을 제조하거나, 구조식(Id)의 화합물 또는 그염을 탈에스테르화하여 구조식(Ie)의 화합물 또는 그염을 제조하거나, 구조식(If)의 화합물 또는 그염을 하이드록실아민 또는 그 산부가염과 반응시켜서 구조식(Ig)의 화합물 또는 그염을 제조하거나, 구조식(If)의 화합물을 환원시켜서 구조식(Ih)의 화합물을 제조하거나, 구조식(III)의 학합물 또는 그 염을 하이드록실아민 또는 그 염과 반응시켜서 구조식(Ii)의 화합물을 제조함을 특징으로 하는 다음구조식(I)의 화합물을 제조하는 방법.
  5. 상기식에서, R1은 수소; 저급알킬; 또는 저급알콕시 페닐, R2는 수소 또는 저급알킬, R3및 R5는 각각 수소이거나; 또는 함께 다음구조식의 기(여기에서 R4와 R6는 다음에 정의한 바와 같다)를 형성하며, R4는 저급알킬, R6는 수소; 또는 저급알킬, R7은수소; 하이드록시이미노메틸; 시아노;포밀피페라진, 카보닐; 알카노일; 에스테르화카복시; 또는 하이드록시나 저급알카노일옥시를 가질수도 있는 저급알킬; 또는 다음 구조식의 기; 여기에서 R8와 R9은 각각 수소; 또는 카복시; 에스테르화카복시, 하이드록시 및 페닐에서 선택된 하나이상의 치환체를 가질수도 있는 저급알킬; 또는 R8와 R9와 함께 피페리딘환을 형성할 수도 있으며, R10은 수소; 또는 카복시나 에스테르화 카복시를 가질수도 있는 저급알킬이다. Ra 7는 시아노; 포밀-피페라진카보닐; 알카노일; 에스테르화카복시; 하이드록시나 저급알카노일옥시를 가질수도 있는 저급알킬; 또는 다음 구조식의 기;, 여기에서 R8와 R9은 각각 수소; 또는 카복시, 에스테르화카복시, 하이드록시 및 페닐에서 선택된 하나이상의 치환체를 가질 수도 있는 저급알킬, 이거나 또는 R8와 R9은 함께 피페리딘 환을 형성할 수도 있다; Ra 10는 카복시 또는 에스테르화카복시를 가질수도 있는 저급 알킬; Rb10는 에스테르화카복시를 가지는 저급알킬; Rc10는 카복시를 가지는 저급알킬이다.
  6. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830006225A 1982-12-31 1983-12-27 신규 니트로 알리파틱 화합물의 제조방법 KR910006761B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8237068 1982-12-31
GB8237068 1982-12-31

Publications (2)

Publication Number Publication Date
KR840007579A true KR840007579A (ko) 1984-12-08
KR910006761B1 KR910006761B1 (ko) 1991-09-02

Family

ID=10535311

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830006225A KR910006761B1 (ko) 1982-12-31 1983-12-27 신규 니트로 알리파틱 화합물의 제조방법

Country Status (18)

Country Link
US (4) US4767768A (ko)
EP (1) EP0113106B1 (ko)
JP (2) JPS59152366A (ko)
KR (1) KR910006761B1 (ko)
AT (1) ATE19773T1 (ko)
AU (1) AU560980B2 (ko)
CA (1) CA1231949A (ko)
DE (1) DE3363550D1 (ko)
DK (1) DK607783A (ko)
ES (1) ES8504682A1 (ko)
FI (1) FI78904C (ko)
GR (1) GR79553B (ko)
HU (1) HU200747B (ko)
IE (1) IE56312B1 (ko)
NO (1) NO158379C (ko)
PH (1) PH19042A (ko)
SU (1) SU1389678A3 (ko)
ZA (1) ZA838831B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601927A1 (de) * 1986-01-23 1987-07-30 Basf Ag Alpha, beta-substituierte acroleine, verfahren zu deren herstellung und deren verwendung
DE3923896A1 (de) * 1989-07-19 1991-01-31 Basf Ag 1-aza-butadiene und diese verbindungen enthaltende fungizide
CA2038716A1 (en) * 1990-03-28 1991-09-29 Yoshio Ueda Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method thereof and drug stabilized thereby
US5254733A (en) * 1990-10-31 1993-10-19 Fujisawa Pharmaceutical Co., Ltd. Process for producing an aliphatic amide and salts thereof
DK0600085T3 (ko) * 1991-08-13 1997-07-07 Fujisawa Pharmaceutical Co
AU2571092A (en) * 1991-09-27 1993-04-27 Fujisawa Pharmaceutical Co., Ltd. Long-acting preparation
US5495023A (en) * 1991-11-15 1996-02-27 Fujisawa Pharmaceutical Co., Ltd. Nitro compounds, process for preparation thereof and use thereof
WO1996005819A1 (fr) * 1994-08-19 1996-02-29 Fujisawa Pharmaceutical Co., Ltd. Remede contre l'hypertension portale
FR2735470B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Nitrocetones et nitroximes, leur preparation et leur application en therapeutique
WO2002002487A1 (en) * 2000-07-03 2002-01-10 Speedel Pharma Ag Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
GB0419693D0 (en) * 2004-09-06 2004-10-06 Givaudan Sa Anti-bacterial compounds
US8580752B2 (en) * 2005-03-31 2013-11-12 Council Of Scientitic And Industrial Research Aromatic amides as potentiators of bioefficacy of anti-infective drugs
ES2429423T3 (es) 2009-11-02 2013-11-14 Firmenich S.A. Sustancias odorantes con notas anisadas
CN103242187B (zh) * 2013-04-28 2016-01-06 华南理工大学 抗菌防腐剂山梨酸氨基酸酯衍生物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1926047A1 (de) * 1968-05-25 1969-12-04 Mitsubishi Chem Ind Verfahren zur Herstellung 6-nitro-2-substituierter Hexansaeureester
NL6907904A (ko) * 1968-05-30 1969-12-02
US3803231A (en) * 1970-12-11 1974-04-09 Allied Chem Ammonolysis of 2-nitro-6-oximino cyclohexanone
US3849481A (en) * 1970-12-11 1974-11-19 Allied Chem Hydrogenation of lysine precursors
US3869481A (en) * 1971-09-16 1975-03-04 Searle & Co 17alpha-alkanoyloxy-6alpha-methyl-3beta-trialkyl-siloxypregn-4-en-20-ones
US3732303A (en) * 1971-10-14 1973-05-08 Allied Chem Process for the preparation of 2-oximino-6-nitro hexanamide
US3746763A (en) * 1971-12-29 1973-07-17 Allied Chem Two-step hydrogenation of lysine amide precursors
US3873301A (en) * 1973-08-09 1975-03-25 Allied Chem Nitro-oximino alkanoic acids as plant growth regulants
US4128581A (en) * 1975-02-27 1978-12-05 Diamond Shamrock Corporation Ketoxime carbamates
US4219660A (en) * 1977-06-24 1980-08-26 Hoffmann-La Roche Inc. Conjugated diene derivatives

Also Published As

Publication number Publication date
US4778804A (en) 1988-10-18
DE3363550D1 (en) 1986-06-19
SU1389678A3 (ru) 1988-04-15
JPS59152366A (ja) 1984-08-31
FI78904C (fi) 1989-10-10
AU560980B2 (en) 1987-04-30
HU200747B (en) 1990-08-28
ZA838831B (en) 1984-07-25
ES528561A0 (es) 1985-05-01
AU2174483A (en) 1984-07-05
ES8504682A1 (es) 1985-05-01
CA1231949A (en) 1988-01-26
JPH02160750A (ja) 1990-06-20
KR910006761B1 (ko) 1991-09-02
IE832788L (en) 1984-06-30
DK607783A (da) 1984-07-01
JPH0219822B2 (ko) 1990-05-07
JPH0417944B2 (ko) 1992-03-26
ATE19773T1 (de) 1986-05-15
PH19042A (en) 1985-12-11
NO158379B (no) 1988-05-24
US4782088A (en) 1988-11-01
US4767768A (en) 1988-08-30
US4863926A (en) 1989-09-05
EP0113106B1 (en) 1986-05-14
IE56312B1 (en) 1991-06-19
EP0113106A1 (en) 1984-07-11
NO158379C (no) 1988-08-31
NO834884L (no) 1984-07-02
DK607783D0 (da) 1983-12-30
FI834702A (fi) 1984-07-01
FI78904B (fi) 1989-06-30
GR79553B (ko) 1984-10-30
FI834702A0 (fi) 1983-12-21

Similar Documents

Publication Publication Date Title
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
KR840007579A (ko) 신규 니트로 알리파틱화합물의 제조방법
KR840004742A (ko) 아졸릴메틸옥시란의 제조방법
KR850004246A (ko) 헤테로-폴리사이클 방향족 화합물의 제법
KR830001214A (ko) 1,2,4,5-테트라-알킬-4-아릴피페리딘
KR840005715A (ko) 3-페녹시-1-아제티딘 카아복사마이드의 제조방법
KR840003674A (ko) N,n'-비스(트리플로로메틸설포닐)옥사이드류 및 이를 함유하는 화학루미네센스 조성물
KR840004065A (ko) 2-시아노-2-프로페노산 및 그 유도체의 제조방법
KR840005426A (ko) 피리딜알킬 나이트레이트 화합물의 제조방법
KR920008054A (ko) 4-에톡시페닐-3-아릴프로필(디메틸)실란의 제조방법
KR840006238A (ko) 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법
KR840007564A (ko) 치환된 벤질사이클로알케닐우레아 유도체의 제조방법
KR840008647A (ko) 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법
KR850005411A (ko) α-메틸-(6-펜옥시)-2- 피콜릴 사이클로프로판 카복실 레이트의 제조방법
KR830001899A (ko) 4-아미노-3-퀴놀린카복실산 및 에스테르-항분비, 항궤양 화합물
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
KR840005815A (ko) I-옥사세팜 화합물의 제조방법
KR850002095A (ko) 4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법
KR850001742A (ko) 큐말산 에스테르의 제조방법
KR840005726A (ko) 고혈압 치료제로서 유용한 치환페닐 피페라진 화합물의 제조방법
KR840002848A (ko) 유기인산염의 제조방법
KR840007010A (ko) 설타미실린 및 동족체의 제조방법
KR850005413A (ko) 아미노니트로피리딘의 제조방법
KR840006200A (ko) 카바메이트의 제조방법
KR840004086A (ko) 1,3,5-트리아크릴일헥사하이드로-s-트리아진-유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19960816

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee